Glucocorticoids and DHEA: Do They Have a Role in Immunosenescence?

  • Moisés E. Bauer
  • Cristina M. Moriguchi Jeckel
  • Cristina Bonorino
  • Flávia Ribeiro
  • Clarice Luz


This chapter summarizes recent work suggesting that human immunosenescence may be closely related to both psychological distress and stress hormones. The age-related immunological changes are also similarly found during chronic stress or glucocorticoid exposure. It follows that endogenous glucocorticoids (cortisol) could be associated to immunosenescence. When compared with young subjects, healthy elders are emotionally distressed in parallel to increased cortisol/ dehydroepiandrosterone (DHEA) ratio. Furthermore, chronic stressed elderly subjects may be particularly at risk of stress-related pathology because of further alterations in glucocorticoid-immune signaling. Although DHEA and its metabolites have been described with immune-enhancing properties, their potential use as hormonal boosters of immunity should be interpreted with caution. The psychoneuroendocrine hypothesis of immunosenescence is presented in which the agerelated increase in the cortisol/DHEA ratio is major determinant of immunological changes observed during aging. We finally discuss that strictly healthy elders are largely protected from chronic stress exposure and show normal cortisol levels and T-lymphocyte function. This information adds a new key dimension on the biology of aging and stress.

Ageing Immunosenescence Glucocorticoids Lymphocytes 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abe M and Thomson AW (2003) Influence of immunosuppressive drugs on dendritic cells. Transpl Immunol 11:357–365PubMedCrossRefGoogle Scholar
  2. Adcock IM, Lane SJ, Brown CR, Lee TH and Barnes PJ (1995) Abnormal glucocorticoid receptoractivator protein 1 interaction in steroid-resistant asthma. J Exp Med 182:1951–1958PubMedCrossRefGoogle Scholar
  3. Agrawal A, Agrawal S, Cao JN, Su H, Osann K and Gupta S (2007a) Altered innate immune functioning of dendritic cells in elderly humans: a role of phosphoinositide 3-kinase-signaling pathway. J Immunol 178:6912–6922Google Scholar
  4. Agrawal A, Agrawal S and Gupta S (2007b) Dendritic cells in human aging. Exp Gerontol 42:421–426CrossRefGoogle Scholar
  5. Araneo B, Woods M and Daynes R (1993) Reversal of the immunosenescent phenotype by dehydroepiandrosterone: hormone treatment provides an adjuvant effect on the immunization of aged mice with recombinant hepatitis B surface antigen. J Infect Dis 167:830–840PubMedGoogle Scholar
  6. Ashworth J, Booker J and Breathnach SM (1988) Effects of topical corticosteroid therapy on Langerhans cell antigen presenting function in human skin. Br J Dermatol 118:457–469PubMedCrossRefGoogle Scholar
  7. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B and Palucka K (2000) Immunobiology of dendritic cells. Annu Rev Immunol 18:767–811PubMedCrossRefGoogle Scholar
  8. Bauer ME (2005) Stress, glucocorticoids and ageing of the immune system. Stress 8:69–83PubMedCrossRefGoogle Scholar
  9. Bauer ME, Papadopoulos A, Poon L, Perks P, Lightman S, Checkley S and Shanks N (2002) Dexamethasone- induced effects on lymphocyte distribution and expression of adhesion molecules in treatment resistant major depression. Psychiatry Res 113:1–15PubMedCrossRefGoogle Scholar
  10. Bauer ME, Papadopoulos A, Poon L, Perks P, Lightman S, Checkley S and Shanks N (2003) Altered glucocorticoid immunoregulation in treatment resistant depression. Psychoneuroendocrinology 28:49–65PubMedCrossRefGoogle Scholar
  11. Bauer ME, Vedhara K, Perks P, Wilcock G, Lightman S and Shanks N (2000) Chronic stress in caregivers of dementia patients is associated with reduced lymphocyte sensitivity to glucocorticoids. J Neuroimmunol 103:84–92PubMedCrossRefGoogle Scholar
  12. Ben-Yehuda A, Danenberg H, Zakay-Rones Z, Gross D and Friedman G (1998) The influence of sequential annual vaccination and DHEA administration on the efficacy of the immune response to influenza vaccine in the elderly. Mech Ageing Dev 102:299–306PubMedCrossRefGoogle Scholar
  13. Besedovsky H, Sorkin E, Felix D and Haas H (1977) Hypothalamic changes during the immune response. Eur J Immunol 7:323–325PubMedCrossRefGoogle Scholar
  14. Bhushan M, Cumberbatch M, Dearman RJ, Andrew SM, Kimber I and Griffiths CE (2002) Tumour necrosis factor-alpha-induced migration of human Langerhans cells: the influence of ageing. Br J Dermatol 146:32–40PubMedCrossRefGoogle Scholar
  15. Biondi M (2001) Effects of Stress on Immune Functions: an overview. In Ader, R et al. (eds.), Psychoneuroimmunonology, Academic Press, San Diego, vol 2, pp 189–226Google Scholar
  16. Bronnegard M, Stierna P and Marcus C (1996) Glucocorticoid resistant syndromes - molecular basis and clinical presentations. J Neuroendocrinol 8:405–415PubMedCrossRefGoogle Scholar
  17. Brossart P and Bevan MJ (1997) Presentation of exogenous protein antigens on major histocompatibility complex class I molecules by dendritic cells: pathway of presentation and regulation by cytokines. Blood 90:1594–1599PubMedGoogle Scholar
  18. Butcher SK and Lord JM (2004) Stress responses and innate immunity: aging as a contributory factor. Aging Cell 3:151–160CrossRefGoogle Scholar
  19. Buvat J (2003) Androgen therapy with dehydroepiandrosterone. World J Urol 21:346–355PubMedCrossRefGoogle Scholar
  20. Canning MO, Grotenhuis K, de Wit HJ and Drexhage HA (2000) Opposing effects of dehydroepiandrosterone and dexamethasone on the generation of monocyte-derived dendritic cells. Eur J Endocrinol 143:687–695PubMedCrossRefGoogle Scholar
  21. Casson PR, Andersen RN, Herrod HG, Stentz FB, Straughn AB, Abraham GE and Buster JE (1993) Oral dehydroepiandrosterone in physiologic doses modulates immune function in postmenopausal women. Am J Obstet Gynecol 169:1536–1539PubMedGoogle Scholar
  22. Castle SC (2000) Clinical relevance of age-related immune dysfunction. Clin Infec Dis 31:578–585CrossRefGoogle Scholar
  23. Castro M, Elliot S, Kino T, Bamberger C, Karl M, Webster E and Chrousos G (1996) The nonligand binding beta-isoform of the human glucocorticoid receptor (hGC-beta): tissue levels, mechanism of action, and potential physiologic role. Molec Med 2:597–607Google Scholar
  24. Collaziol D, Luz C, Dornelles F, Cruz I and Bauer ME (2004) Psychoneuroendocrine correlates of lymphocyte subsets during healthy ageing. Mech Ageing Dev 125:219–227PubMedCrossRefGoogle Scholar
  25. Corpas S, Harman M and Blackmann MR (1993) Human Growth Hormone and Human Aging. Endocr Rev 14:20–39PubMedGoogle Scholar
  26. Danenberg H, Ben-Yehuda A, Zakay-Rones Z and Friedman G (1995) Dehydroepiandrosterone (DHEA) treatment reverses the impaired immune response of old mice to influenza vaccination and protects from influenza infection. Vaccine 13:1445–1448PubMedCrossRefGoogle Scholar
  27. Danenberg HD, Ben-Yehuda A, Zakay-Rones Z, Gross DJ and Friedman G (1997) Dehydroepiandrosterone treatment is not beneficial to the immune response to influenza in elderly subjects. J Clin Endocrinol Metab 82:2911–2914PubMedCrossRefGoogle Scholar
  28. Daynes R, Araneo B, Ershler W, Maloney C, Li G-Z and Ryu S-Y (1993) Altered regulation of IL-6 production with normal aging—possible linkage to the age-associated decline in dehydroepiandrosterone and its sulfated derivative. J Immunol 150:5219–5230PubMedGoogle Scholar
  29. Daynes R, Dudley D and Araneo B (1990) Regulation of murine lymphokine production in vivo. II. Dehydroepiandrosterone is a natural enhancer of interleukin-2 synthesis by helper T cells. Eur J Immunol 20:793–802PubMedCrossRefGoogle Scholar
  30. de Kloet ER, Vreugdenhil E, Oitzl MS and Joels M (1998) Brain corticosteroid receptor balance in health and disease. Endocr Rev 19:269–301PubMedCrossRefGoogle Scholar
  31. Degelau J, Guay D and Hallgren H (1997) The effect of DHEAS on influenza vaccination in aging adults. J Am Geriatr Soc 45:747–751PubMedGoogle Scholar
  32. Deuschle M, Gotthardt U, Schweiger U, Weber B, Korner A, Schmider J, Standhardt H, Lammers C and Heuser I (1997) With aging in humans the activity of the hypothalamus-pituitary-adrenal system increases and its amplitude flattens. Life Sci 61:2239–2246PubMedCrossRefGoogle Scholar
  33. Dew MA, Reynolds CF, Frank E, Begley AE, Miller MD, Cornes C, Mazumdar S, Perel JM and Kupfer DJ (1998) Effects of age at onset of first lifetime episode of recurrent major depression on treatment response and illness course in elderly patients. Am J Psychiatry 155:759–799Google Scholar
  34. Di Santo E, Sironi M and Mennini T (1996) A glucocorticoid receptor independent mechanism for neurosteroid inhibition of tumor necrosis factor production. Eur J Pharmacol 299:179–186PubMedCrossRefGoogle Scholar
  35. Dixit VD, Schaffer EM, Pyle RS, Collins GD, Sakthivel SK, Palaniappan R, Lillard JW, Jr. and Taub DD (2004) Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J Clin Invest 114:57–66PubMedGoogle Scholar
  36. Elenkov IJ, Chrousos GP and Wilder RL (2000) Neuroendocrine regulation of IL-12 and TNFalpha/ IL-10 balance. Clinical implications. Ann N Y Acad Sci 917:94–105PubMedCrossRefGoogle Scholar
  37. Englander EW, Gomez GA and Greeley GH, Jr. (2004) Alterations in stomach ghrelin production and in ghrelin-induced growth hormone secretion in the aged rat. Mech Ageing Dev 125:871–875PubMedCrossRefGoogle Scholar
  38. Epel ES, Blackburn EH, Lin J, Dhabhar FS, Adler NE, Morrow JD and Cawthon RM (2004) Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci U S A 101:17312–17315PubMedCrossRefGoogle Scholar
  39. Evans TG, Judd ME, Dowell T, Poe S, Daynes RA and Araneo BA (1996) The use of oral dehydroepiandrosterone sulfate as an adjuvant in tetanus and influenza vaccination of the elderly. Vaccine 14:1531–1537PubMedCrossRefGoogle Scholar
  40. Fagiolo U, Cossarizza A, Scala E, Fanales-Belasio E, Ortolani C, Cozzi E, Monti D, Franceschi C and Paganelli R (1993) Increased cytokine production in mononuclear cells of healthy elderly people. Eur J Immunol 23:2375–2378PubMedCrossRefGoogle Scholar
  41. Fauci A (1975) Mechanisms of corticosteroid action on lymphocyte subpopulations. Immunology 28:669–679PubMedGoogle Scholar
  42. Ferrari E, Arcaini A, Gornati R, Pelanconi L, Cravello L, Fioravanti M, Solerte SB and Magri F (2000) Pineal and pituitary-adrenocortical function in physiological aging and in senile dementia. Exp Gerontol 35:1239–1250PubMedCrossRefGoogle Scholar
  43. Ferrari E, Cravello L, Muzzoni B, Casaritti D, Paltro M, Sorlete SB, Fioravanti M, Cuzzoni G, Pontiggia B and Magri F (2001) Age-related changes of the hypothalamic-pytuitary-adrenal axis: phathophysiological correlates. Eur J Endocrinol 144:319–329PubMedCrossRefGoogle Scholar
  44. Ferrari E, Mirani M, Barili L, Falvo F, Solerte SB, Cravello L, Pini L and Magri F (2004) Cognitive and affective disorders in the elderly: a neuroendocrine study. Arch Gerontol Geriatr Suppl:171–182Google Scholar
  45. Fontenot JD, Gavin MA and Rudensky AY (2003) Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4:330–336PubMedCrossRefGoogle Scholar
  46. Gabriel H, Schmitt B and Kindermann W (1993) Age-related increase of CD45RO+ lymphocytes in physically active adults. Eur J Immunol 23:2704–2706PubMedCrossRefGoogle Scholar
  47. Gabriel P, Cakman I and Rink L (2002) Overproduction of monokines by leukocytes after stimulation with lipopolysaccharide in the elderly. Exp Gerontol 37:235–247PubMedCrossRefGoogle Scholar
  48. Galon J, Franchimont D, Hiroi N, Frey G, Boetner A, Ehrart-Bornstein M, O’Shea J, Chrousos GP and Bornstein S (2002) Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J 16:61–71PubMedCrossRefGoogle Scholar
  49. Ginaldi L, Loreto MF, Corsi MP, Modesti M and De Martinis M (2001) Immunosenescence and infectious diseases. Microbes Infect 3:851–857PubMedCrossRefGoogle Scholar
  50. Glaser R, McCallum R, Laskowski BF, Malarkey WB, Sheridan J and Kiecolt-Glaser J (2001) Evidence for a shift in the Th-1 to Th-2 cytokine response associated with chronic stress and aging. J Gerontol Med Sci 56A:M477–M482Google Scholar
  51. Glaser R, Sheridan J, Malarkey WB, MacCallum RC and Kiecolt-Glaser JK (2000) Chronic stress modulates the immune response to a pneumococcal pneumonia vaccine. Psychosom.Med. 62: 804–807.PubMedGoogle Scholar
  52. Globerson A and Effros R (2000) Ageing of lymphocytes and lymphocytes in the aged. Immunol. Today 21:515–521PubMedCrossRefGoogle Scholar
  53. Gold P, Goodwin F and Chrousos G (1988) Clinical and biochemical manifestations of depression I. N Engl J Med 319:348–413PubMedGoogle Scholar
  54. Gold R, Buttgereit F and Toyka KV (2001) Mechanism of action of glucocorticosteroid hormones: possible implications for therapy of neuroimmunological disorders. J Neuroimmunol 117:1–8PubMedCrossRefGoogle Scholar
  55. Grasso G, Lodi L, Lupo C and Muscettola M (1997) Glucocorticoid receptors in human peripheral blood mononuclear cells in relation to age and to sport activity. Life Sci 61:301–308PubMedCrossRefGoogle Scholar
  56. Grewe M (2001) Chronological ageing and photoageing of dendritic cells. Clin Exp Dermatol 26:608–612PubMedCrossRefGoogle Scholar
  57. Halbreich U, Asnis G, Zumoff B, Nathan R and Shindledecker R (1984) Effect of age and sex on cortisol secretion in depressives and normals. Psychiatry Res 13:221–229PubMedCrossRefGoogle Scholar
  58. Hannet I, Erkeller-Yuksel F, Lydyard P, Deneys V and DeBruyere M (1992) Developmental and maturational changes in human blood lymphocyte subpopulations. Immunol Today 13:215, 218PubMedCrossRefGoogle Scholar
  59. Hattori N, Ikekubo K, Ishihara T, Moridera K, Hino M and Kurahachi N (1994) Spontaneous Growth Hormone (GH) Secretion by Unstimulated Human Lymphocytes and the Effects of GH-Releasing Hormone and Somatostatin. J Clin Endocrinol Metab 79:1678–1680PubMedCrossRefGoogle Scholar
  60. Hearing SD, Norman M, Smyth C, Foy C and Dayan CM (1999) Wide variation in lymphocyte steroid sensitivity among healthy human volunteers. J Clin Endocrinol Metab 84:4149–4154PubMedCrossRefGoogle Scholar
  61. Hechter O, Grossman A and Chatterton RT (1997) Relationship of dehydroepiandrosterone and cortisol in disease. Med Hypotheses 49:85–91PubMedCrossRefGoogle Scholar
  62. Henson SM, Pido-Lopez J and Aspinall R (2004) Reversal of thymic atrophy. Exp Gerontol 39:673–678PubMedCrossRefGoogle Scholar
  63. Heuser I, Deuschle M, Luppa P, Schweiger U, Standhadt H and Weber B (1998) Increased diurnal plasma concentrations of dehydroepiandrosterone in depressed patients. J Clin Endocrinol Metab 83:3130–3133PubMedCrossRefGoogle Scholar
  64. Hoglund CO, Axen J, Kemi C, Jernelov S, Grunewald J, Muller-Suur C, Smith Y, Gronneberg R, Eklund A, Stierna P and Lekander M (2006) Changes in immune regulation in response to examination stress in atopic and healthy individuals. Clin Exp Allergy 36:982–992PubMedCrossRefGoogle Scholar
  65. Howieson DB, Camicioli R, Quinn J, Silbert LC, Care B, Moore MM, Dame A, Sexton G and Kaye JA (2003) Natural history of cognitive decline in the old old. Neurology 60:1489–1494PubMedGoogle Scholar
  66. Huether G (1996) The central adaptation syndrome: psychosocial stress as a trigger for adaptive modifications of brain structure and brain function. Prog Neurobiol 48:569–612PubMedCrossRefGoogle Scholar
  67. Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S, Muramatsu S and Steinman RM (1992) Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 176:1693–1702PubMedCrossRefGoogle Scholar
  68. Juruena MF, Cleare AJ, Bauer ME and Pariante CM (2003) Molecular mechanisms of glucocorticoid receptor sensitivity and relevance to affective disorders. Acta Neuropsychiatr 15:354–367CrossRefGoogle Scholar
  69. Kam J, Szefler S, Surs W, Sher E and Leung D (1993) Combination of IL-2 and IL-4 reduces glucocorticoid receptor- binding affinity and T cell response to glucocorticoids. J Immunol 151:3460–3466PubMedGoogle Scholar
  70. Kavelaars A, Cats B, Visser G, Zegers B, Bakker J, Van Rees E and Heijnen C (1996) Ontogeny of the response of human peripheral blood T cells to glucocorticoids. Brain Behav Immun 10:288–297PubMedCrossRefGoogle Scholar
  71. Kiecolt-Glaser J, Dura J, Speicher C, Trask J and Glaser R (1991) Spousal caregivers of dementia victims: longitudinal changes in immunity and health. Psychosom Med 53:345–362PubMedGoogle Scholar
  72. Kiecolt-Glaser J, Glaser R, Gravenstein S, Malarkey W and Sheridan J (1996) Chronic stress alters the immune response to influenza virus vaccine in older adults. Proc Natl Acad Sci U S A 93:3043–3047PubMedCrossRefGoogle Scholar
  73. Kiecolt-Glaser J, Marucha P, Malarkey W, Mercado A and Glaser R (1995) Slowing of wound healing by psychological stress. Lancet 346:1194–1196PubMedCrossRefGoogle Scholar
  74. Kiecolt-Glaser JK, Preacher KJ, MacCallum RC, Atkinson C, Malarkey WB and Glaser R (2003) Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proc Natl Acad Sci USA 100:9090–9095PubMedCrossRefGoogle Scholar
  75. Kirschbaum C, Pirke KM and Hellhammer DH (1993) The ‘Trier Social Stress Test’–a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology 28:76–81PubMedCrossRefGoogle Scholar
  76. Kirschbaum C, Prussner J, Stone A, Federenko I, Gaab J, Lintz D, Schommer N and Hellhammer D (1995) Persistent high cortisol responses to repeated psychological stress in a subpopulation of healthy men. Psychol Med 57:468–474Google Scholar
  77. Lee AL, Ogle WO and Sapolsky RM (2002) Stress and depression: possible links to neuron death in the hippocampus. Bipolar Disord 4:117–128PubMedCrossRefGoogle Scholar
  78. Ligthart G, Corberand J, Fournier C, Galanaud P, Humans W, Kennes B, Möller-Hermelink H and Steinmann G (1984) Admission criteria for immunogerontological studies in man: the SENIEUR protocol. Mech Ageing Dev 28:47–55PubMedCrossRefGoogle Scholar
  79. Liu J, Wang S, Liu H, Yang L and Nan G (1997) The monitoring biomarker for immune function os lymphocytes in the elderly. Mech Ageing Dev 94:177–182PubMedCrossRefGoogle Scholar
  80. Lung TL, Saurwein-Teissl M, Parson W, Schonitzer D and Grubeck-Loebenstein B (2000) Unimpaired dendritic cells can be derived from monocytes in old age and can mobilize residual function in senescent T cells. Vaccine 18:1606–1612PubMedCrossRefGoogle Scholar
  81. Luo X, Tarbell KV, Yang H, Pothoven K, Bailey SL, Ding R, Steinman RM and Suthanthiran M (2007) Dendritic cells with TGF-beta1 differentiate naive CD4+CD25- T cells into islet-protective Foxp3+ regulatory T cells. Proc Natl Acad Sci U S A 104:2821–2826PubMedCrossRefGoogle Scholar
  82. Lupien S, Lecours A, Lussier I, Schwartz G, Nair N and Meaney M (1994) Basal cortisol levels and cognitive deficits in human aging. J Neurosci 14:2893–2903PubMedGoogle Scholar
  83. Luz C, Collaziol D, Preissler T, da Cruz IM, Glock L and Bauer ME (2006) Healthy Aging Is Associated with Unaltered Production of Immunoreactive Growth Hormone but Impaired Neuroimmunomodulation. Neuroimmunomodulation 13:160–169PubMedCrossRefGoogle Scholar
  84. Luz C, Dornelles F, Preissler T, Collaziol D, Cruz I and Bauer ME (2003) Impact of psychological and endocrine factors on cytokine production of healthy elderly people. Mech Ageing Dev 124:887–895PubMedCrossRefGoogle Scholar
  85. Luz C, Dornelles F, Scapini E, Collaziol D, Preissler T, Cruz I and Bauer ME (2002) Psychological and nutritional correlates of T-cell function in the healthy elderly. Stress 5:80–80Google Scholar
  86. Maeda K, Tanimoto K, Terada T, Shintani T and Kakigi T (1991) Elevated urinary free cortisol in patients with dementia. Neurobiol Aging 12:161–163PubMedCrossRefGoogle Scholar
  87. Maes M, Scharp S, Meltzer H, Bosmans E, Suy E, Calabrese J and Cosyns P (1993) Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary- adrenal axis in severe depression. Psychiatry Res 49:11–27PubMedCrossRefGoogle Scholar
  88. Malarkey WB, Wang J, Cheney C, Glaser R and Nagaraja H (2002) Human lymphocyte growth hormone stimulates interferon gamma production and is inhibited by cortisol and norepinephrine. J Neuroimmunol 123:180–187PubMedCrossRefGoogle Scholar
  89. Martinez-Taboada V, Bartolome MJ, Amado JA, Blanco R, Garcia-Unzueta MT, Rodriguez-Valverde V and Lopez-Hoyos M (2002) Changes in peripheral blood lymphocyte subsets in elderly subjects are associated with an impaired function of the hypothalamic-pituitary- adrenal axis. Mech Ageing Dev 123:1477–1486PubMedCrossRefGoogle Scholar
  90. Mastorakos G, Chrousos GP and Weber J (1993) Recombinant IL-6 activates the hypothalamicpituitary- adrenal axis in humans. J Clin Endocrinol Metab 77:1690–1694PubMedCrossRefGoogle Scholar
  91. Matthews JG, Ito K, Barnes PJ and Adcock IM (2004) Defective glucocorticoid receptor nuclear translocation and altered histone acetylation patterns in glucocorticoid-resistant patients. J Allergy Clin Immunol 113:1100–1108PubMedCrossRefGoogle Scholar
  92. Matyszak MK, Citterio S, Rescigno M and Ricciardi-Castagnoli P (2000) Differential effects of corticosteroids during different stages of dendritic cell maturation. Eur J Immunol 30:1233–1242PubMedCrossRefGoogle Scholar
  93. McEwen B (1998) Protective and damaging effects of stress mediators. New Engl J Med 338:171–179PubMedCrossRefGoogle Scholar
  94. McEwen B, Biron C, Brunson K, Bulloch K, Chambers W, Dhabhar F, Goldfarb R, Kitson R, Miller A, Spencer R and Weiss J (1997) The role of adrenocorticosteroids as modulators of immune function in health and disease: neural, endocrine and immune interactions. Brain Res Rev 23:79–133PubMedCrossRefGoogle Scholar
  95. McEwen BS (2003) Interacting mediators of allostasis and allostatic load: towards an understanding of resilience in aging. Metabolism 52:10–16PubMedCrossRefGoogle Scholar
  96. McLachlan JA, Serkin CD and Bakouche O (1996) Dehydroepiandrosterone modulation of lipopolysaccharide-stimulated monocyte cytotoxicity. J Immunol 156:328–335PubMedGoogle Scholar
  97. Migeon C, Keller A, Lawrence B and Shepard T (1957) Dehydroepiandrosterone and androsterone levels in human plasma: effects of age, sex, day to day diurnal variations. J Clin Endocrinol Metab 17:1051PubMedGoogle Scholar
  98. Muller DN, Shagdarsuren E, Park JK, Dechend R, Mervaala E, Hampich F, Fiebeler A, Ju X, Finckenberg P, Theuer J, Viedt C, Kreuzer J, Heidecke H, Haller H, Zenke M and Luft FC (2002) Immunosuppressive treatment protects against angiotensin II-induced renal damage. Am J Pathol 161:1679–1693PubMedGoogle Scholar
  99. Murasko D, Weiner P and Kaye D (1987) Decline in mitogen induced proliferation of lymphocytes with increasing age. Clin Exp Immunol 70:440–448PubMedGoogle Scholar
  100. Nagata S and Golstein P (1995) The Fas death factor. Science 267:1449–1456PubMedCrossRefGoogle Scholar
  101. Navarro J, Aristimuno C, Sanchez-Ramon S, Vigil D, Martinez-Gines ML, Fernandez-Cruz E and de Andres C (2006) Circulating dendritic cells subsets and regulatory T-cells at multiple sclerosis relapse: differential short-term changes on corticosteroids therapy. J Neuroimmunol 176:153–161PubMedCrossRefGoogle Scholar
  102. Nijhuis EW, Hinloopen B, van Lier RA and Nagelkerken L (1995) Differential sensitivity of human naive and memory CD4+ T cells for dexamethasone. Int Immunol 7:591–5PubMedCrossRefGoogle Scholar
  103. Nolen-Hoeksema S and Ahrens C (2002) Age differences and similarities in the correlates of depressive symptoms. Psychol Aging 17:116–124PubMedCrossRefGoogle Scholar
  104. Oka M, Hirazawa K, Yamamoto K, Iizuka N, Hazama S, Suzuki T and Kobayashi N (1996) Induction of Fas-mediated apoptosis on circulating lymphocytes by surgical stress. Ann Surg 223:434–440PubMedCrossRefGoogle Scholar
  105. Padgett DA and Loria R (1994) In vitro potentiation of lymphocyte activation by dehydroepiandrosterone, androstenediol, and androstenetriol. J Immunol 153:1544–1552PubMedGoogle Scholar
  106. Pan J, Ju D, Wang Q, Zhang M, Xia D, Zhang L, Yu H and Cao X (2001) Dexamethasone inhibits the antigen presentation of dendritic cells in MHC class II pathway. Immunol Lett 76:153–161PubMedCrossRefGoogle Scholar
  107. Pariante C, Pearce B, Pisell T, Sanshez C, Po C, Su C and Miller A (1999a) The proinflammatory cytokine, interleukin-1a, reduces glucocorticoid receptor translocation and function. Endocrinology 140:4359–4366CrossRefGoogle Scholar
  108. Pariante CM, Pearce BD, Pisell TL, Sanchez CI, Po C, Su C and Miller AH (1999b) The proinflammatory cytokine, interleukin-1alpha, reduces glucocorticoid receptor translocation and function. Endocrinology 140:4359–4366CrossRefGoogle Scholar
  109. Pawelec G, Barnett Y, Forsey R, Frasca D, Globerson A, McLeod J, Caruso C, Franceschi C, Fulop T, Gupta S, Mariani E, Mocchegiani E and Solana R (2002) T cells and aging, January 2002update. Front Biosci 7:D1056–D1183PubMedGoogle Scholar
  110. Pereira M, Traverse M, Barros D, Bianchini A and Martinez P (2003) The effects of aging on leukocyte glucocorticoid receptor concentration and response to dexamethasone in dogs. Exp Gerontol 38:989–995PubMedCrossRefGoogle Scholar
  111. Piani A, Brotini S, Dolso P, Budai R and Gigli GL (2004) Sleep disturbances in elderly: a subjective evaluation over 65. Arch Gerontol Geriatr Suppl:325–331Google Scholar
  112. Picard D, Khursheed B, Garabedian MJ, Fortin MG, Lindquist S and Yamamoto KR (1990) Reduced levels of hsp90 compromise steroid receptor action in vivo. Nature 348:166–168PubMedCrossRefGoogle Scholar
  113. Pietschmann P, Hahn P, Kudlacek S, Thomas R and Peterlik M (2000) Surface markers and transendothelial migration of dendritic cells from elderly subjects. Exp Gerontol 35:213–224PubMedCrossRefGoogle Scholar
  114. Potestio M, Pawelec G, Di Lorenzo G, Candore G, D’Anna C, Gervasi F, Lio D, Tranchida G, Caruso C and Romano GC (1999) Age-related changes in the expression of CD95 (APO1/FAS) on blood lymphocytes. Exp Gerontol 34:659–673PubMedCrossRefGoogle Scholar
  115. Ramirez F, Fowell D, Puklavec M, Simmonds S and Mason D (1996) Glucocorticoids promote a Th2 cytokine response by CD4+ T cells in vitro. J Immunol 156:2406–2412PubMedGoogle Scholar
  116. Raskind M, Peskind E and Wilkinson C (1994) Hypothalamic-pituitary-adrenal axis regulation and human aging. Ann N Y Acad Sci 746: 327–335PubMedGoogle Scholar
  117. Redinbaugh E, McCallum R and Kiecolt-Glaser J (1995) Recurrent syndromal depression in caregivers. Psychol Aging:358–368Google Scholar
  118. Ribeiro F, Lopes RP, Nunes CP, Maito F, Bonorino C and Bauer ME (2007) Dehydroepiandrosterone sulphate enhances IgG and Interferon-gamma production during immunization to tuberculosis in young but not aged mice. Biogerontology 8:209–220PubMedCrossRefGoogle Scholar
  119. Rohleder N, Kudielka BM, Hellhammer DH, Wolf JM and Kirschbaum C (2002) Age and sex steroid-related changes in glucocorticoid sensitivity of pro-inflammatory cytokine production after psychosocial stress. J Neuroimmunol 126:69–77PubMedCrossRefGoogle Scholar
  120. Rohleder N, Wolf JM and Kirschbaum C (2003) Glucocorticoid sensitivity in humans-interindividual differences and acute stress effects. Stress 6:207–222PubMedCrossRefGoogle Scholar
  121. Roshan S, Nader S and Orlander P (1999) Ageing and hormones. Eur J Clin Invest 29:210–213PubMedCrossRefGoogle Scholar
  122. Sakaguchi S (2000) Regulatory T cells: key controllers of immunologic self-tolerance. Cell 101:455–458PubMedCrossRefGoogle Scholar
  123. Salehian MB and Kejriwal MK (1999) Glucocorticoid-induced muscle atrophy: mechanisms and therapeutic strategies. Endocr Pract 5:277–281PubMedGoogle Scholar
  124. Sapolsky RM, Krey LC and McEwen BS (1986) The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocr Rev 7:284–301PubMedCrossRefGoogle Scholar
  125. Sapolsky RM, Romero LM and Munck AU (2000) How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev 21:55–89PubMedCrossRefGoogle Scholar
  126. Schiepers OJ, Wichers MC and Maes M (2005) Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry 29:201–217PubMedCrossRefGoogle Scholar
  127. Schmidt M, Lugering N, Lugering A, Pauels HG, Schulze-Osthoff K, Domschke W and Kucharzik T (2001) Role of the CD95/CD95 ligand system in glucocorticoid-induced monocyte apoptosis. J Immunol 166:1344–1351PubMedGoogle Scholar
  128. Schulz R and Beach SR (1999) Caregiving as a risk factor for mortality: the caregiver health effects study. JAMA 282:2215–2219PubMedCrossRefGoogle Scholar
  129. Selye H (1936) Syndrome produced by diverse nocuous agents. Nature 138:32CrossRefGoogle Scholar
  130. Sharma S, Dominguez AL and Lustgarten J (2006) Aging affect the anti-tumor potential of dendritic cell vaccination, but it can be overcome by co-stimulation with anti-OX40 or anti-4-1BB. Exp Gerontol 41:78–84PubMedCrossRefGoogle Scholar
  131. Shaw WS, Patterson TL, Ziegler MG, Dimsdale JE, Semple SJ and Grant I (1999) Accelerated risk of hypertensive blood pressure recordings among Alzheimer caregivers. J Psychosom Res 46:215–227PubMedCrossRefGoogle Scholar
  132. Silva C, Powell-Oliver F, Jewell C, Sar M, Allgood V and Cidlowski J (1994) Regulation of the human glucocorticoid receptor by long-term and chronic treatment with glucocorticoid. Steroids 59:436–442PubMedCrossRefGoogle Scholar
  133. Sippell WG, Becker H, Versmold HT, Bidlingmaier F and Knorr D (1978) Longitudinal studies of plasma aldosterone, corticosterone, deoxycorticosterone, progesterone, 17-hydroxyprogesterone, cortisol, and cortisone determined simultaneously in mother and child at birth and during the early neonatal period. I. Spontaneous delivery. J Clin Endocrinol Metab 46:971–985PubMedCrossRefGoogle Scholar
  134. Solerte SB, Fioravanti M, Vignati G, Giustina A, Cravello L and Ferrari E (1999) Dehydroepiandrosterone sulfate enhances natural killer cell cytotoxicity in humans via locally generated immunoreactive insulin- like growth factor I. J Clin Endocrinol Metab 84:3260–3267PubMedCrossRefGoogle Scholar
  135. Spahn J, Szefler S, Surs W, Doherty D, Nimmagadda S and Leung D (1996) A novel action of IL-13: induction of diminished monocyte glucocorticoid receptor-binding affinity. J Immunol 157:2654–2659PubMedGoogle Scholar
  136. Starkman M, Schteingart D and Schork M (1981) Depressed mood and other psychiatric manifestations of Cushing’s syndrome: relationship to hormone levels. Psychosom Med 43:3–18CrossRefGoogle Scholar
  137. Steger MM, Maczek C and Grubeck-Loebenstein B (1997) Peripheral blood dendritic cells reinduce proliferation in in vitro aged T cell populations. Mech Ageing Dev 93:125–130PubMedCrossRefGoogle Scholar
  138. Steinman RM (2003) Some interfaces of dendritic cell biology. APMIS 111:675–697PubMedCrossRefGoogle Scholar
  139. Sternberg E (2002) Neuroendocrine regulation of autoimmune/inflammatory disease. J Endocrinol 169:429–435CrossRefGoogle Scholar
  140. Straub R, Miller L, Scholmerich J and Zietz B (2000) Cytokines and hormones as possible links between endocrinosenescence and immunosenescence. J Neuroimmunol 109:10–15PubMedCrossRefGoogle Scholar
  141. Straub R, Schölmerich J and Cutolo M (2003) The multiple facets of premature aging in rheumatoid arthritis. Arthritis Rheum 48:2713–2721PubMedCrossRefGoogle Scholar
  142. Straub RH, Cutolo M, Zietz B and Scholmerich J (2001) The process of aging changes the interplay of the immune, endocrine and nervous systems. Mech Ageing Dev 122:1591–1611PubMedCrossRefGoogle Scholar
  143. Straub RH, Konecna L, Hrach S, Rothe G, Kreutz M, Scholmerich J, Falk W and Lang B (1998) Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man in vitro: possible link between endocrinosenescence and immunosenescence. J Clin Endocrinol Metab 83:2012–2017PubMedCrossRefGoogle Scholar
  144. Suzuki T, Suzuki N, Daynes R and Engleman E (1991) Dehydroepiandrosterone enhances IL2 production and cytotoxic effector function of human T cells. Clin Immunol Immunop 61:202–211CrossRefGoogle Scholar
  145. Tamura Y, Okinaga H and Takami H (2004) Glucocorticoid-induced osteoporosis. Biomed Pharmacother 58:500–504PubMedGoogle Scholar
  146. Truckenmiller ME, Princiotta MF, Norbury CC and Bonneau RH (2005) Corticosterone impairs MHC class I antigen presentation by dendritic cells via reduction of peptide generation. J Neuroimmunol 160:48–60PubMedCrossRefGoogle Scholar
  147. Trzonkowski P, Mysliwska J, Godlewska B, Szmit E, Lukaszuk K, Wieckiewicz J, Brydak L, Machala M, Landowski J and Mysliwski A (2004) Immune consequences of the spontaneous pro-inflammatory status in depressed elderly patients. Brain Behav Immun 18: 135–148PubMedCrossRefGoogle Scholar
  148. Trzonkowski P, Szmit E, Mysliwska J and Mysliwski A (2006) CD4+CD25+ T regulatory cells inhibit cytotoxic activity of CTL and NK cells in humans-impact of immunosenescence. Clin Immunol 119:307–316PubMedCrossRefGoogle Scholar
  149. Van Cauter E, Leproult R and Kupfer DJ (1996) Effects of gender and age on the levels and circadian rhythmicity of plasma cortisol. J Clin Endocrinol Metab 81:2468–2473PubMedCrossRefGoogle Scholar
  150. Vedhara K, Cox N, Wilcock G, Perks P, Lightman S and Shanks N (1999) Chronic stress in elderly carers of dementia patients and antibody response to influenza vaccination. Lancet 353:627–631PubMedCrossRefGoogle Scholar
  151. Vetta F, Ronzoni S, Lupatelli M, Novi B, Fabbriconi P, Ficconeri C, Cicconetti P, Russo F and Bollea M (2001) Tumor necrosis factor-alpha and mood disorders in the elderly. Arch Gerontol Geriatr Suppl 7:442Google Scholar
  152. Vitaliano PP, Scanlan JM, Zhang J, Savage MV, Hirsch IB and Siegler IC (2002) A path model of chronic stress, the metabolic syndrome, and coronary heart disease. Psychosom Med 64:418–435PubMedGoogle Scholar
  153. Vremec D and Shortman K (1997) Dendritic cell subtypes in mouse lymphoid organs: cross-correlation of surface markers, changes with incubation, and differences among thymus, spleen, and lymph nodes. J Immunol 159:565–573PubMedGoogle Scholar
  154. Weigent DA, Baxter JB, Wear WE, Smith LR, Bost KL and Blalock JE (1988) Production of immunoreactive growth hormone by mononuclear leukocytes. FASEB J 2:2812–2818PubMedGoogle Scholar
  155. Yamazaki S, Inaba K, Tarbell KV and Steinman RM (2006) Dendritic cells expand antigen-specific Foxp3+ CD25+ CD4+ regulatory T cells including suppressors of alloreactivity. Immunol Rev 212:314–329PubMedCrossRefGoogle Scholar
  156. Yin D, Tuthill D, Mufson RA and Shi Y (2000) Chronic restraint stress promotes lymphocyte apoptosis by modulating CD95 expression. J Exp Med 191:1423–1428PubMedCrossRefGoogle Scholar
  157. Zavala WD and Cavicchia JC (2006) Deterioration of the Langerhans cell network of the human gingival epithelium with aging. Arch Oral Biol 51:1150–1155PubMedCrossRefGoogle Scholar
  158. Zhang TY, Ding X and Daynes RA (2005) The expression of 11 beta-hydroxysteroid dehydrogenase type I by lymphocytes provides a novel means for intracrine regulation of glucocorticoid activities. J Immunol 174:879–889PubMedGoogle Scholar
  159. Zipp F, Wendling U, Beyer M, Grieger U, Waiczies S, Wagenknecht B, Haas J and Weller M (2000) Dual effect of glucocorticoids on apoptosis of human autoreactive and foreign antigenspecific T cells. J Neuroimmunol 110:214–222PubMedCrossRefGoogle Scholar
  160. Zovato S, Simoncini M, Gottardo C, Pratesi C, Vampollo V and Spigariol A (1996) Dexamethasone suppression test: corticosteroid receptors regulation in mononuclear leukocytes of young and aged subjects. Aging Clin Exp Res 8:360–364Google Scholar

Copyright information

© Springer Science+Business Media B.V. 2009

Authors and Affiliations

  • Moisés E. Bauer
    • 1
  • Cristina M. Moriguchi Jeckel
    • 2
  • Cristina Bonorino
    • 1
  • Flávia Ribeiro
    • 3
  • Clarice Luz
    • 4
  1. 1.Faculdade de Biociências Instituto de Pesquisas BiomédicasPontifícia Universidade Católica do Rio Grande do Sul (PUCRS)Porto AlegreBrazil
  2. 2.Faculdade de FarmáciaPUCRSPorto AlegreBrazil
  3. 3.Ageing and Tumour Immunology GroupUniversity of Tübingen Sektion Transplantionsimmunologie / ImmunhämatologieTübingenGermany
  4. 4.LabVitrusRua GaribaldiPorto AlegreBrazil

Personalised recommendations